Table 5

Proportion of pathogenic mutations predicted in both genes by scoring in the combined dataset (sets 1 and 2)

Manchester score BRCA1 BRCA2
25+40/51 (78%)9/12 (75%)
20–2421/42 (50%)7/14 (50%)
15–1936/99 (36%)20/61 (33%)
12–1420/101 (20%)15/71 (21%)
10–119/76 (11.8%)10/64 (15.6%)
8–94/104 (3.8%)3/70 (4.3%)
1–72/141 (1.4%)3/136 (2.2%)
Total132/614 (21.4%)67/428 (15.7%)